Samer Mouksassi

1.3k total citations · 1 hit paper
37 papers, 974 citations indexed

About

Samer Mouksassi is a scholar working on Epidemiology, Pharmacology and Surgery. According to data from OpenAlex, Samer Mouksassi has authored 37 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Pharmacology and 6 papers in Surgery. Recurrent topics in Samer Mouksassi's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Statistical Methods in Clinical Trials (4 papers) and Pharmaceutical studies and practices (3 papers). Samer Mouksassi is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Statistical Methods in Clinical Trials (4 papers) and Pharmaceutical studies and practices (3 papers). Samer Mouksassi collaborates with scholars based in United States, Canada and United Kingdom. Samer Mouksassi's co-authors include Jean‐Francois Marier, Martin Béliveau, Juan José Pérez Ruixo, Thi Huyen Tram Nguyen, Immanuel Freedman, Mats O. Karlsson, Radojka M. Savić, Nicholas H. G. Holford, France Mentré and Diane R. Mould and has published in prestigious journals such as American Journal of Clinical Nutrition, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

Samer Mouksassi

36 papers receiving 946 citations

Hit Papers

Model Evaluation of Continuous Data Pharmacometric Models... 2016 2026 2019 2022 2016 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics
    2016 292 citations Thi Huyen Tram Nguyen, Samer Mouksassi et al. CPT Pharmacometrics & Systems Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samer Mouksassi United States 15 207 184 174 123 123 37 974
Jakob Ribbing Sweden 10 174 0.8× 126 0.7× 141 0.8× 117 1.0× 44 0.4× 21 1.0k
Eric Snoeck Belgium 18 103 0.5× 176 1.0× 96 0.6× 187 1.5× 104 0.8× 44 1.1k
Jin‐Sying Lin United States 15 118 0.6× 181 1.0× 133 0.8× 85 0.7× 100 0.8× 34 1.2k
Wing K. Cheung United States 18 194 0.9× 250 1.4× 131 0.8× 173 1.4× 45 0.4× 43 1.4k
Alison E. Fohner United States 18 107 0.5× 140 0.8× 122 0.7× 115 0.9× 145 1.2× 47 962
Nidal Al‐Huniti United States 21 226 1.1× 226 1.2× 166 1.0× 135 1.1× 35 0.3× 72 1.4k
Ganesh Cherala United States 18 106 0.5× 234 1.3× 230 1.3× 57 0.5× 47 0.4× 45 1.0k
Hazem Elewa Qatar 22 106 0.5× 202 1.1× 84 0.5× 231 1.9× 55 0.4× 80 1.3k
Hülya Yılmaz Türkiye 24 124 0.6× 489 2.7× 91 0.5× 88 0.7× 166 1.3× 134 1.8k
Hieronymus A.M. Voorbij Netherlands 27 170 0.8× 176 1.0× 282 1.6× 202 1.6× 146 1.2× 62 2.0k

Countries citing papers authored by Samer Mouksassi

Since Specialization
Citations

This map shows the geographic impact of Samer Mouksassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samer Mouksassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samer Mouksassi more than expected).

Fields of papers citing papers by Samer Mouksassi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samer Mouksassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samer Mouksassi. The network helps show where Samer Mouksassi may publish in the future.

Co-authorship network of co-authors of Samer Mouksassi

This figure shows the co-authorship network connecting the top 25 collaborators of Samer Mouksassi. A scholar is included among the top collaborators of Samer Mouksassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samer Mouksassi. Samer Mouksassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asiimwe, Innocent G., Samer Mouksassi, Goonaseelan Pillai, et al.. (2025). Postmarketing Assessment of Antibody–Drug Conjugates: Proof‐of‐Concept Using Model‐Based Meta‐Analysis and a Clinical Utility Index Approach. CPT Pharmacometrics & Systems Pharmacology. 14(11). 1810–1822. 1 indexed citations
2.
Mouksassi, Samer, et al.. (2025). Quantifying natural amyloid plaque accumulation in the continuum of Alzheimer’s disease using ADNI. Journal of Pharmacokinetics and Pharmacodynamics. 52(1). 15–15. 2 indexed citations
3.
Jamil, Zehra, Kelley VanBuskirk, Samer Mouksassi, et al.. (2024). Anthropometry relationship with duodenal histologic features of children with environmental enteric dysfunction: a multicenter cross-sectional study. American Journal of Clinical Nutrition. 120. S65–S72. 4 indexed citations
4.
VanBuskirk, Kelley, Shyam S. Raghavan, Tahmeed Ahmed, et al.. (2024). Multiplexed immunohistochemical evaluation of small bowel inflammatory and epithelial parameters in environmental enteric dysfunction. American Journal of Clinical Nutrition. 120. S31–S40. 5 indexed citations
5.
Hofmann, Daniela, Michael Buettcher, Goonaseelan Pillai, et al.. (2024). Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d’Ivoire. Drugs in R&D. 24(2). 331–340. 1 indexed citations
6.
Asiimwe, Innocent G., et al.. (2024). Machine-Learning Assisted Screening of Correlated Covariates: Application to Clinical Data of Desipramine. The AAPS Journal. 26(4). 63–63. 3 indexed citations
7.
Pillai, Goonaseelan, Samer Mouksassi, Innocent G. Asiimwe, et al.. (2024). Advancing pharmacometrics in Africa—Transition from capacity development toward job creation. CPT Pharmacometrics & Systems Pharmacology. 14(3). 407–419. 1 indexed citations
8.
Mandema, Jaap W., Hugh Montgomery, Louis Dron, et al.. (2023). Totality of evidence of the effectiveness of repurposed therapies for COVID‐19: Can we use real‐world studies alongside randomized controlled trials?. Clinical and Translational Science. 16(10). 1842–1855. 1 indexed citations
9.
Dodds, Michael, Yuan Xiong, Samer Mouksassi, et al.. (2021). Model‐informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospection. British Journal of Clinical Pharmacology. 87(9). 3388–3397. 9 indexed citations
10.
Mouksassi, Samer, et al.. (2019). Population Pharmacokinetic/Pharmacodynamic Modeling of O-Desmethyltramadol in Young and Elderly Healthy Volunteers. Drugs & Aging. 36(8). 747–758. 4 indexed citations
11.
Perrone, Ronald D., Samer Mouksassi, Klaus Romero, et al.. (2017). A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease. Kidney International Reports. 2(3). 451–460. 18 indexed citations
12.
Nguyen, Thi Huyen Tram, Samer Mouksassi, Nicholas H. G. Holford, et al.. (2016). Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics. CPT Pharmacometrics & Systems Pharmacology. 6(2). 87–109. 292 indexed citations breakdown →
13.
Ouellet, Danièle, Nastya Kassir, Samer Mouksassi, et al.. (2016). Population pharmacokinetics and exposure–response of trametinib, a MEK inhibitor, in patients with BRAF V600 mutation-positive melanoma. Cancer Chemotherapy and Pharmacology. 77(4). 807–817. 42 indexed citations
14.
15.
Nehus, Edward, Samer Mouksassi, Alexander A. Vinks, & Stuart L. Goldstein. (2014). Meropenem in children receiving continuous renal replacement therapy: Clinical trial simulations using realistic covariates. The Journal of Clinical Pharmacology. 54(12). 1421–1428. 20 indexed citations
16.
Leeds, Janet M., Nathalie Gosselin, Samer Mouksassi, et al.. (2012). Pharmacokinetic and Pharmacodynamic Modeling To Determine the Dose of ST-246 To Protect against Smallpox in Humans. Antimicrobial Agents and Chemotherapy. 57(3). 1136–1143. 19 indexed citations
17.
Marier, Jean‐Francois, et al.. (2009). Population Pharmacokinetics of Teduglutide Following Repeated Subcutanenous Administrations in Healthy Participants and in Patients With Short Bowel Syndrome and Crohn's Disease. The Journal of Clinical Pharmacology. 50(1). 36–49. 40 indexed citations
18.
19.
Marier, Jean‐Francois, Martin Béliveau, Samer Mouksassi, et al.. (2008). Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon‐Like Peptide‐2 (GLP‐2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects. The Journal of Clinical Pharmacology. 48(11). 1289–1299. 65 indexed citations
20.
Michaud, Véronique, Samer Mouksassi, Line Labbé, et al.. (2006). Inhibitory Effects of Propafenone on the Pharmacokinetics of Caffeine in Humans. Therapeutic Drug Monitoring. 28(6). 779–783. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jakob Ribbing Breakdown of academic impact, for papers by Eric Snoeck Breakdown of academic impact, for papers by Jin‐Sying Lin Breakdown of academic impact, for papers by Wing K. Cheung Breakdown of academic impact, for papers by Alison E. Fohner Breakdown of academic impact, for papers by Nidal Al‐Huniti Breakdown of academic impact, for papers by Ganesh Cherala Breakdown of academic impact, for papers by Hazem Elewa Breakdown of academic impact, for papers by Hülya Yılmaz Breakdown of academic impact, for papers by Hieronymus A.M. Voorbij
Rankless by CCL
2026